25 May 2013
Keywords: lamivudine, improves, liver, histology, hepatitis, glaxo, wellcome
Article | 21 April 1997
Glaxo Wellcome and BioChem Pharma have reported the results of a PhaseIII study of lamivudine in patients with hepatitis B ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 1997
10 April 1997
24 May 2013
© 2013 thepharmaletter.com